Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066098
Filing Date
2014-11-07
Accepted
2014-11-07 16:30:40
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392713_10-q.htm 10-Q 326981
2 EXHIBIT 31.01 v392713_ex31-01.htm EX-31.01 9052
3 EXHIBIT 31.02 v392713_ex31-02.htm EX-31.02 8745
4 EXHIBIT 32.01 v392713_ex32-01.htm EX-32.01 5719
  Complete submission text file 0001144204-14-066098.txt   3306744

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tnxp-20140930.xml EX-101.INS 374409
6 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20140930.xsd EX-101.SCH 47040
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20140930_cal.xml EX-101.CAL 28127
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20140930_def.xml EX-101.DEF 266071
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20140930_lab.xml EX-101.LAB 301562
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20140930_pre.xml EX-101.PRE 289905
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 141205284
SIC: 2834 Pharmaceutical Preparations